News
Ibrutinib linked to hypertension in B-cell malignancies
- Author:
- Caleb Rans
New or worsening hypertension was also linked with a greater risk of major adverse cardiac events.
News

Adverse cytogenetics trump molecular risk in NPM1-mutated AML
- Author:
- Caleb Rans
The findings have implications for postremission treatment decisions, including whether NPM1-mutated patients should receive allogeneic...
News

Monthly and twice monthly emicizumab dosing safe for children with severe hemophilia A
- Author:
- Caleb Rans
The small study confirms the safety of twice-monthly or monthly emicizumab administration for children with severe hemophilia A without inhibitors...
News

New consensus recommendations on bleeding in acquired hemophilia
- Author:
- Caleb Rans
The key areas addressed in the global expert consensus statement include the initial management of bleeding and management of location-specific...
News
Eltrombopag elicits positive responses in secondary ITP
- Author:
- Caleb Rans
The drug appears safe among patients with ITP secondary to lymphoproliferative disorders, but more study is needed to determine the potential risk...
News

Novel research aims to improve ED care in sickle cell disease
- Author:
- Caleb Rans
Researchers are testing the best acute pain management strategies to respond to a vasoocclusive crisis.
News

Apple cider vinegar soaks fall short in atopic dermatitis
- Author:
- Caleb Rans
Acetic acid, particularly apple cider vinegar, has become prominent among emerging natural remedies for atopic dermatitis.
News

Ongoing research aims to improve transplant outcomes in sickle cell
- Author:
- Caleb Rans
Over the past 2 years, the majority of novel transplant techniques have been primarily aimed at improving conditioning regimens and lowering rates...
News

A quarter of ICU admissions caused by substance abuse
- Author:
- Caleb Rans
Polysubstance abuse was the most frequent subcategory of illicit and prescription drug admissions.
News

Novel gene therapies show promise for sickle cell cure
- Author:
- Caleb Rans
Gene-addition and gene-editing therapies are currently in clinical development.
News

Genetic analysis highlights value of germline variants in MDS, AML
- Author:
- Caleb Rans
Systematic genetic testing for DDX41 mutations may aid in clinical decision making for adults with MDS or AML.
News

Study confirms prognostic impact of MYC partner gene in DLBCL
- Author:
- Caleb Rans
The findings suggest that clinicians should adopt diagnostic strategies to identify this high-risk cohort of patients.
News
VRD pretransplant induction deepens responses in myeloma
- Author:
- Caleb Rans
The researchers wrote that the unique dosing of the three-drug induction regimen may be considered a new standard of care.
News
Metformin-TKI combo improves PFS in EGFR-mutated lung cancer
- Author:
- Caleb Rans
Combination metformin and epidermal growth factor receptor–tyrosine kinase inhibitor (EGFR-TKI) therapy improved progression-free survival in...
News

Rituximab, bendamustine look better than chemo alone in MCL
- Author:
- Caleb Rans
The research confirms the benefit of adding novel agents to chemotherapy regimens in older patients with mantle cell lymphoma.